SEC Filings

Document Details

Form
Filing Date
Feb 14, 2020
Document Date
Dec 31, 2019
Form Description
Annual filing director officer or owner of more than ten percent.
Filing Group
3,4,5
Company
Aimmune Therapeutics
Issuer
Aimmune Therapeutics, Inc.